Analyst Ranking
Bottom 3%
#4809 out of 4922 analysts
Average Return
-9.63%
Win Rate
34%39 out of 115
Risk vs Reward
Poor
Good

David Turkaly's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neuronetics IncSTIM
+325.30%$0.83$3.53
2024-08-13 -
2025-06-27
Buy
Icad IncICAD
+99.77%$8.88$17.74
2020-02-04 -
2021-02-05
Buy
Lantheus Holdings IncLNTH
+67.88%$64.32$107.98
2023-11-02 -
2024-11-01
Buy
Paragon 28 IncFNA
+58.67%$8.25$13.09
2024-05-08 -
2025-04-17
Buy
Si Bone IncSIBN
+34.91%$12.69$17.12
2022-11-07 -
2023-11-07
Buy

David Turkaly Analyst Color

Get additional color on David Turkaly's coverage of popular stocks

David Turkaly's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Haemonetics CorpHAE
9Buy$100.00+35.50%Reiterates
a month ago
Steris PLCSTE
15Buy$280.00+17.26%Maintains
a month ago
Integra Lifesciences Holdings CorpIART
13Buy$25.00+103.42%Maintains
2 months ago
Enovis CorpENOV
2Buy$55.00+73.06%Maintains
2 months ago
Zimmer Biomet Holdings IncZBH
11Buy$125.00+36.67%Maintains
2 months ago
Crowdstrike Holdings IncCRWD
1Buy$500.00+0.13%Maintains
2 months ago
Tela Bio IncTELA
6Buy$7.00+255.33%Maintains
3 months ago
Orthopediatrics CorpKIDS
10Buy$50.00+133.97%Reiterates
3 months ago
Axogen IncAXGN
5Buy$26.00+147.62%Reiterates
4 months ago
Si Bone IncSIBN
6Buy$32.00+73.63%Reiterates
4 months ago
Snap IncSNAP
1Buy$16.00+83.49%Reiterates
5 months ago
Lantheus Holdings IncLNTH
8Buy$112.00+37.44%Reiterates
6 months ago
Neuronetics IncSTIM
4Buy$3.00-15.01%Maintains
a year ago
Paragon 28 IncFNA
4Buy$20.00N/AMaintains
a year ago
Teleflex IncTFX
10Buy$285.00N/AReiterates
a year ago
Nevro CorpNVRO
5Buy$40.00N/AMaintains
2 years ago
Icad IncICAD
4Buy$4.00N/AMaintains
2 years ago
Apyx Medical CorpAPYX
1Buy$14.00N/AMaintains
4 years ago
Cognyte Software LtdCGNT
1Buy$5.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.